Related Experiment Video
Updated: Sep 5, 2025

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling
Published on: June 23, 2022
Preadmission testing for COVID-19 as a screening strategy: a retrospective chart review from a tertiary hospital in
David Echesa Odada1, James Ndai1, Jemimah Kimeu1
1Department of Nursing, Aga Khan University Hospital, Nairobi, Kenya.
Insights
Pre-admission COVID-19 testing identified a 10.9% prevalence rate, with 14.3% of positive cases being incidental. This highlights the importance of mandatory screening to control asymptomatic transmission in healthcare settings.
Area of Science:
- Infectious Diseases
- Public Health
- Hospital Administration
Background:
- Hospitals faced challenges protecting staff and patients from COVID-19 due to asymptomatic transmission.
- Controlling COVID-19 exposure is difficult when patients can transmit the virus without symptoms.
Purpose of the Study:
- To evaluate pre-admission COVID-19 testing as a screening strategy.
- To understand, prevent, and control COVID-19 exposure at Aga Khan University Hospital, Nairobi.
Main Methods:
- Descriptive retrospective chart review study.
- Analyzed incidence, incidental detection, and impact on care plans for pre-admission COVID-19 cases.
- Retrieved demographic, clinical, and testing data from patient records (April-December 2020).
Main Results:
- A total of 8,837 pre-admission tests revealed a 10.9% COVID-19 prevalence.
- 14.3% of positive cases were incidentally detected.
- Incidental positives led to affected care plans (21%), delayed interventions (14.5%), and altered hospital stays.
Conclusions:
- Pre-admission COVID-19 prevalence increased throughout 2020.
- Mandatory testing is crucial for controlling asymptomatic transmission.
- Universal pre-admission screening is justified by the COVID-19 health burden.
Background:
Since COVID-19 was declared a pandemic in March 2020, hospitals and patient care facilities have faced challenges in protecting healthcare workers and patients from being exposed to the infection. The main challenge has been how exposure to COVID-19 can be controlled when asymptomatic patientscan transmit the infection. This study aims to evaluate pre-admission testing of COVID-19 in patients at the Aga Khan University Hospital, Nairobi as a screening strategy for understanding, preventing and controlling exposure to COVID-19.
Methods:
This was a descriptive retrospective chart review study that analysed the incidence of COVID-19, incidental detection of laboratory-confirmed COVID-19 and effects on plan of care in patients prior to admission at the Aga Khan University Hospital from April to December 31, 2020. Demographic data, clinical characteristics, COVID-19 test report and plan of care were retrieved from patients medical records review.
Results:
A total of 8837 pre-admission tests were done between April 2020 and December 2020, with a COVID-19 prevalence rate of 10.9% (961/8837). Among the positive pre-admission tests, 14.3% were incidental positive results (138/961). Among the 138 incidental positive tests 21% (30) had their plan of care affected, 14.5% [20] had their care interventions delayed, 4.3% [6] had their hospital stay shortened, 1.4% [2] their hospital stay prolonged and 0.7% [1] had their care diagnostics delayed.
Conclusion:
While community spread of COVID-19 fluctuated during this period; depending on the level of compliance to infection control measures, pre-admission prevalence rates were increasing as the year progressed. Mandatory testing of COVID-19 in hospital facilities remains an important admission requirement in controlling asymptomatic transmission of the virus. COVID-19 health burden justifies resource allocation for universal screening of all patients before hospital admission.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Interpreting Run Charts
Pneumonia III: Complications and Assessment
Guidelines and Strategies for Safe Computer Charting
Maintain Confidentiality and Security:
Preventive Healthcare Services
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

